It was today that Plandai Biotechnology Inc (OTCMKTS:PLPL) held a debate regarding its expansion plans into the future. The business giant seeks to maximize the sales of its non-psychoactive cannabis extract by a significant margin. Everything is already set in place and it hopes to take advantage of the various International Nutraceutical Cannabis Opportunities that will be coming its way.
Analysts have made their projections about the future and in a joint statement they have outlined that immense growth will have been witnessed by the moment 2022 arrives. The company has been undertaking research on the function-specific antioxidants for over quite some time. It has said that the findings will help create opportunities for the company’s products.
A close outlook into recent developments
Plandai Biotechnology Inc asserts that its cannabis extract will play a significant part towards the growth of the emerging market. The passage of time is witnessing a lot of people embrace Cannabis and its benefits in a great way. For its medicinal benefits, the product is being used by people in many countries including Italy, Israel, Greece, Denmark, Chile, Canada, Australia and Argentina.
This company’s COO while addressing a number of news reporters opined, “Our focus is on getting a full-profile, non-psychoactive cannabis extract product to market as quickly as possible so that customers can have access to a wellness product that specifically targets the pain receptors of the human endocannabinoid system.”
He believes that the various persons that have been struggling with devastating conditions will be quite pleased with the introduction of the non-psychoactive, non-addictive pain reliever.
Most of the patients around the globe prefer the treatment of pain symptoms using cannabis. But it is also crucial to mention that experts did not advocate that for everyone. There are those patients that are usually impacted negatively by using such products. The chronic sufferers, the elderly and above all children are some of the groups that don’t augur quite well with the remedy.
A lot of discussions have taken root lately. The other significant one is about the business giant focus on the benefits associated with the SORBEO™ proprietary PREMIX. It is a rather cost effective formulation that will help enhance the United States poultry industry.